
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. (LEXX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LEXX · as of Jun 9, 2026
Key Statistics
Explore Lexaria Bioscience Corp. Data
lexx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The LEXX analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $1.50, representing +131.98% upside from the current price of $0.65.
Competitors & Peers
lexx competitorsStock Performance
Full HistoryAbout Lexaria Bioscience Corp.
Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of act…
what is lexaria bioscience corp. · lexx stock overview · lexaria bioscience corp. company profile · who is lexaria bioscience corp. ceo · lexx NASDAQ · lexaria bioscience corp. headquarters · lexaria bioscience corp. business segments
About Stock Overview & Key Data
Lexaria Bioscience Corp. (LEXX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 12, 2021. As of the latest trading session, LEXX stock price is $0.65, with a market capitalization of $13.2M. The stock has returned -35.34% over the past 12 months and +4.80% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Lexaria Bioscience Corp. stock is Buy, with an average 12-month price target of $1.50. In fiscal year 2025, Lexaria Bioscience Corp. reported revenue of $705923.00 and net income of -$11.9M. For detailed data — including Lexaria Bioscience Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lexaria Bioscience Corp. (LEXX) stock price is $0.65. The stock is traded on NASDAQ under the ticker symbol LEXX. The 52-week range is $0.46 – $1.55.